Published by the Students of Johns Hopkins since 1896
April 27, 2025April 27, 2025 | Published by the Students of Johns Hopkins since 1896
ZG8_9544-E.jpg
·
COURTESY OF ELEDON PHARMACEUTICALS
Eledon Pharmaceuticals, Inc. (Eledon), is a biotechnology company. In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C. Gros, discussed the latest updates regarding their tegoprubart treatment.
COURTESY OF ELEDON PHARMACEUTICALS
Eledon Pharmaceuticals, Inc. (Eledon), is a biotechnology company. In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C. Gros, discussed the latest updates regarding their tegoprubart treatment.